Greenberger L M, Lothstein L, Williams S S, Horwitz S B
Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461.
Proc Natl Acad Sci U S A. 1988 Jun;85(11):3762-6. doi: 10.1073/pnas.85.11.3762.
A family of P-glycoproteins are overproduced in multidrug-resistant cells derived from the murine macrophage-like line J774.2. To determine whether individual family members are overproduced in response to different drugs, the P-glycoprotein precursors in several independently isolated cell lines, which were selected for resistance to vinblastine or taxol, were compared. Individual cell lines selected with vinblastine overproduced P-glycoprotein precursors of either 120 or 125 kDa. Taxol-selected cell lines overproduced either the 125-kDa precursor or both precursors simultaneously. Two similar but distinct peptide maps for the mature P-glycoproteins were observed. These maps corresponded to each precursor regardless of the drug used for selection. One vinblastine-resistant cell line switched from the 125- to the 120-kDa precursor when grown in increasing concentrations of drug. This change coincided with the overexpression of a distinct subset of mRNA species that code for P-glycoprotein. It is concluded that precursor expression is not drug-specific. These data suggest that individual overproduced P-glycoprotein family members are translated as distinct polypeptides. The results may help to explain the diversity in the multidrug-resistant phenotype.
在源自鼠巨噬细胞样细胞系J774.2的多药耐药细胞中,一个P-糖蛋白家族过量产生。为了确定单个家族成员是否因不同药物而过量产生,对几个独立分离的细胞系中的P-糖蛋白前体进行了比较,这些细胞系是为对长春碱或紫杉醇产生抗性而选择的。用长春碱选择的单个细胞系过量产生120 kDa或125 kDa的P-糖蛋白前体。用紫杉醇选择的细胞系过量产生125 kDa的前体或同时过量产生两种前体。观察到成熟P-糖蛋白有两个相似但不同的肽图。无论用于选择的药物如何,这些图谱都与每种前体相对应。一个长春碱抗性细胞系在药物浓度增加的情况下生长时,从125 kDa的前体转变为120 kDa的前体。这种变化与编码P-糖蛋白的不同mRNA种类的过表达同时发生。得出的结论是,前体表达不是药物特异性的。这些数据表明,单个过量产生的P-糖蛋白家族成员被翻译为不同的多肽。这些结果可能有助于解释多药耐药表型的多样性。